首页 > 最新文献

American Journal of Obstetrics & Gynecology Mfm最新文献

英文 中文
Reply to: Letter to the editor regarding “The feasibility and effectiveness of using an adhesion barrier in preventing dysmenorrhea, pain, and niche-related problems after cesarean sections” 回复:关于“使用粘连屏障预防剖宫产术后痛经、疼痛及与生态位相关问题的可行性和有效性”的致编辑信。
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-25 DOI: 10.1016/j.ajogmf.2025.101843
Britt L. Post MD, Judith A.F. Huirne MD, PhD, Robert A. de Leeuw PhD
{"title":"Reply to: Letter to the editor regarding “The feasibility and effectiveness of using an adhesion barrier in preventing dysmenorrhea, pain, and niche-related problems after cesarean sections”","authors":"Britt L. Post MD, Judith A.F. Huirne MD, PhD, Robert A. de Leeuw PhD","doi":"10.1016/j.ajogmf.2025.101843","DOIUrl":"10.1016/j.ajogmf.2025.101843","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 3","pages":"Article 101843"},"PeriodicalIF":3.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147318640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Placental cytogenetic testing for confined placental mosaicism and obstetrical outcomes after discordant cell-free DNA screening results 无细胞DNA筛查结果不一致后,限制性胎盘嵌合体的胎盘细胞遗传学检测和产科结局。
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-09 DOI: 10.1016/j.ajogmf.2025.101887
Yvette Raymond PhD, MD, BMedSc(Hons) , Shavi Fernando PhD, MBBS(Hons), BMedSc(Hons) , Melody Menezes PhD, BSc(Hons), GDipGenetCouns , Ben W. Mol PhD, MD, MSc , Emma Brown BSc , Kirsten Arnold MD, BMedSc , Daniel L. Rolnik PhD, MD, MSc, MPH

BACKGROUND

A false-positive cell-free DNA prenatal screening result may arise from confined placental mosaicism, however, the frequency and obstetrical ramifications of such cases are poorly understood.

OBJECTIVE

This study aimed to assess the prevalence of confined placental mosaicism among pregnancies with false-positive cell-free DNA results and the associated obstetrical outcomes.

STUDY DESIGN

This was a prospective, matched-cohort study with a 1:2 ratio of cases with false-positive cell-free DNA results and controls with low-risk cell-free DNA results that were matched by maternal age and body mass index. Participants were recruited between November 2022 and March 2025 at Monash Health and Monash Ultrasound for Women in Melbourne, Australia. Cytogenetic testing was conducted on 4 biopsies per placenta to investigate confined placental mosaicism. The cases and matched controls were compared using trio matching identifiers as random effect in conditional logistic regression and linear mixed-effects modelling.

RESULTS

A total of 60 cases with false-positive cell-free DNA results were matched with 120 controls. Confined placental mosaicism was observed in 20 of the 60 cases (33.3%) and in none of the controls. The prevalence of confined placental mosaicism was highest among those with rare autosomal trisomy (57.9%; 11/19) and monosomy X (75.5%; 3/4) results. Confined placental mosaicism was also observed following common autosomal trisomy results (21.4%; 3/14) and subchromosomal copy number variants (15.8%; 3/19). The median birth weight percentile was significantly lower among instances of confirmed confined placental mosaicism (20.1; interquartile range, 9.9–48.5) than among matched controls (43.5; interquartile range, 17.1–66.1; P=.049); however, there were no statistically significant increases in small-for-gestational-age neonates or other adverse pregnancy outcomes.

CONCLUSION

Confined placental mosaicism is a frequent contributor to false-positive cell-free DNA results, most often for monosomy X and rare autosomal trisomy results. Although the birth weight median percentiles were lower, the outcomes of cell-free DNA–detected confined placental mosaicism in this average-risk cohort were predominantly favorable.
El resumen está disponible en Español al final del artículo.

Video Abstract

Download: Download video (8MB)

Video Raymond. Confined placental mosaicism and obstetrical outcomes after discordant cell-free DNA screening. Am J Obstet Gynecol MFM 2026.

背景:无细胞DNA (cfDNA)产前筛查结果假阳性可能是由局限性胎盘嵌合体(CPM)引起的,尽管这种情况的频率和产科后果尚不清楚。目的:评估假阳性cfDNA结果中CPM的患病率以及相关的产科结局。研究设计:这是一项前瞻性匹配队列研究,cfDNA假阳性病例和低风险cfDNA对照组的比例为1:2,与母亲年龄和体重指数(BMI)相匹配。参与者于2022年11月至2025年3月在澳大利亚墨尔本的莫纳什健康和莫纳什妇女超声中心招募。对每个胎盘进行4次活检进行细胞遗传学检测以研究CPM。使用条件逻辑回归和线性混合效应模型,将病例和匹配对照进行随机效应的三人匹配标识符比较。结果:60例cfDNA假阳性与120例对照相匹配。60例患者中有20例(33.3%)出现CPM,对照组中无CPM。罕见常染色体三体(RAT)(57.9%, 11/19)和X单体(75.5%,3/4)中CPM患病率最高。在常见常染色体三体(21.4%,3/14)和亚染色体拷贝数变异(15.8%,3/19)结果中也观察到CPM。确诊CPM病例的出生体重百分位数中位数(20.1,四分位数间距(IQR) 9.9 - 48.5)显著低于匹配对照组(43.5,IQR 17.1 - 66.1, p = 0.049);然而,小胎龄新生儿或其他不良妊娠结局没有统计学上的显著增加。结论:CPM是导致cfDNA结果假阳性的常见因素,最常见的是X单体和RAT结果。虽然出生体重中位数较低,但在这个平均风险队列中,cfdna检测的CPM结果主要是有利的。
{"title":"Placental cytogenetic testing for confined placental mosaicism and obstetrical outcomes after discordant cell-free DNA screening results","authors":"Yvette Raymond PhD, MD, BMedSc(Hons) ,&nbsp;Shavi Fernando PhD, MBBS(Hons), BMedSc(Hons) ,&nbsp;Melody Menezes PhD, BSc(Hons), GDipGenetCouns ,&nbsp;Ben W. Mol PhD, MD, MSc ,&nbsp;Emma Brown BSc ,&nbsp;Kirsten Arnold MD, BMedSc ,&nbsp;Daniel L. Rolnik PhD, MD, MSc, MPH","doi":"10.1016/j.ajogmf.2025.101887","DOIUrl":"10.1016/j.ajogmf.2025.101887","url":null,"abstract":"<div><h3>BACKGROUND</h3><div>A false-positive cell-free DNA prenatal screening result may arise from confined placental mosaicism, however, the frequency and obstetrical ramifications of such cases are poorly understood.</div></div><div><h3>OBJECTIVE</h3><div>This study aimed to assess the prevalence of confined placental mosaicism among pregnancies with false-positive cell-free DNA results and the associated obstetrical outcomes.</div></div><div><h3>STUDY DESIGN</h3><div>This was a prospective, matched-cohort study with a 1:2 ratio of cases with false-positive cell-free DNA results and controls with low-risk cell-free DNA results that were matched by maternal age and body mass index. Participants were recruited between November 2022 and March 2025 at Monash Health and Monash Ultrasound for Women in Melbourne, Australia. Cytogenetic testing was conducted on 4 biopsies per placenta to investigate confined placental mosaicism. The cases and matched controls were compared using trio matching identifiers as random effect in conditional logistic regression and linear mixed-effects modelling.</div></div><div><h3>RESULTS</h3><div>A total of 60 cases with false-positive cell-free DNA results were matched with 120 controls. Confined placental mosaicism was observed in 20 of the 60 cases (33.3%) and in none of the controls. The prevalence of confined placental mosaicism was highest among those with rare autosomal trisomy (57.9%; 11/19) and monosomy X (75.5%; 3/4) results. Confined placental mosaicism was also observed following common autosomal trisomy results (21.4%; 3/14) and subchromosomal copy number variants (15.8%; 3/19). The median birth weight percentile was significantly lower among instances of confirmed confined placental mosaicism (20.1; interquartile range, 9.9–48.5) than among matched controls (43.5; interquartile range, 17.1–66.1; <em>P</em>=.049); however, there were no statistically significant increases in small-for-gestational-age neonates or other adverse pregnancy outcomes.</div></div><div><h3>CONCLUSION</h3><div>Confined placental mosaicism is a frequent contributor to false-positive cell-free DNA results, most often for monosomy X and rare autosomal trisomy results. Although the birth weight median percentiles were lower, the outcomes of cell-free DNA–detected confined placental mosaicism in this average-risk cohort were predominantly favorable.</div><div>El resumen está disponible en Español al final del artículo.</div></div><div><h3>Video Abstract</h3><div><span><span><span><span><video><source></source></video></span><span><span>Download: <span>Download video (8MB)</span></span></span></span><span><span><p>Video Raymond. Confined placental mosaicism and obstetrical outcomes after discordant cell-free DNA screening. Am J Obstet Gynecol MFM 2026.</p></span></span></span></span></div></div>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 3","pages":"Article 101887"},"PeriodicalIF":3.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145953312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between partner status and postpartum depression among participants in a perinatal mental health collaborative care program. 围产期心理健康合作护理项目参与者的伴侣状况与产后抑郁的关系
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-19 DOI: 10.1016/j.ajogmf.2026.101920
Adam K Lewkowitz, Emma Allen, Allie Sakowicz, Nina K Ayala, Laurie B Griffin, Cynthia L Battle, Caron Zlotnick, William A Grobman, Emily S Miller
{"title":"Association between partner status and postpartum depression among participants in a perinatal mental health collaborative care program.","authors":"Adam K Lewkowitz, Emma Allen, Allie Sakowicz, Nina K Ayala, Laurie B Griffin, Cynthia L Battle, Caron Zlotnick, William A Grobman, Emily S Miller","doi":"10.1016/j.ajogmf.2026.101920","DOIUrl":"10.1016/j.ajogmf.2026.101920","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":" ","pages":"101920"},"PeriodicalIF":3.1,"publicationDate":"2026-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146776743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antihypertensive agent of choice following hypertensive disorders of pregnancy: future directions. 妊娠高血压疾病后抗高血压药物的选择:未来方向。
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-12 DOI: 10.1016/j.ajogmf.2026.101913
Carrie Bennett, Hyagriv Simhan, Alisse Hauspurg
{"title":"Antihypertensive agent of choice following hypertensive disorders of pregnancy: future directions.","authors":"Carrie Bennett, Hyagriv Simhan, Alisse Hauspurg","doi":"10.1016/j.ajogmf.2026.101913","DOIUrl":"10.1016/j.ajogmf.2026.101913","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":" ","pages":"101913"},"PeriodicalIF":3.1,"publicationDate":"2026-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146198076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cervical stiffness in mid-pregnancy: a predictive tool using a novel aspiration device for spontaneous preterm birth risk assessment 妊娠中期颈椎僵硬:使用新型吸吸装置进行自发性早产风险评估的预测工具。
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-01 Epub Date: 2025-12-05 DOI: 10.1016/j.ajogmf.2025.101867
Irene Hösli MD, PhD, Gundula Hebisch MD, Michael Bajka MD, Katharina Quack Lötscher MPH MD, Alice Winkler MD, Leonhard Schäffer MD, PhD, Begoña Martinez de Tejada MD, PhD, Monya Todesco Bernasconi MD, Tina Fischer MD, Vincent Uerlings MD, Jute Richter MD, PhD, Stephanie Von Orelli MD, Markus Kuther MD, Elke Prentl MD, Ursula Fellmann MD, Alexander Krafft MD, Lea Köchli MD, Sabrina Badir DSc, David Scheiner MD

Video Abstract

Download: Download video (3MB)
目的:目前的早产(PTB)风险评估标准是经阴道超声测量宫颈长度。acl 1,2。宫颈软化一直被认为是妊娠期间宫颈状态的重要描述参数,由于技术的进步,它重新被认为具有改善自发性PTB (sPTB)风险评估的潜力。在这项研究中,我们评估了妊娠中期用基于吸气的妊娠系统4测量的宫颈僵硬度在最终足月分娩的孕妇和自然早产的孕妇之间的差异;我们评估了刚度在预测sPTB中的性能。研究设计:我们在13个中心对18-55岁的孕妇进行了一项横断面、前瞻性、队列研究(NCT02037334)。临床人群包括在常规妊娠中期咨询(妊娠180/7 - 220/7周)能够给予知情同意的妇女。排除和退出标准为活动性出血,膜早破(PROM),活动性生殖器感染,已知HIV或乙型或丙型肝炎携带者,前置胎盘,勒氏管异常,已知或疑似研究不符合,药物或酒精滥用,环扎或子宫托,以及CL 4。通过最大宫颈压缩性比(宫颈一致性指数,CCI)和经阴道测量的宫颈长度来确定刚度。疼痛或不适评分(0 -无疼痛至10 -最大可能疼痛),并记录分娩信息。结果:在1002名入组妇女中,990名为单胎妊娠。整个数据集的早产率(5.2%)大大低于预期,52例早产中有25例是自然发生的。单胎妊娠发生sPTB的妇女妊娠中期平均CSI(中位数=65 mbar, IQR=(41,70), n=19)显著低于足月分娩的妇女(71 mbar, (51,97), n=948)。CL和CCI无显著差异(见表1)。先前阴道分娩(VD)与宫颈柔软密切相关:在足月单胎妊娠中,有VD的妇女(64 mbar, (45,85), n=358)的CSI比没有VD的妇女(75 mbar, (55,103), n=590)的CSI低15%(结论:自然早产的单胎妊娠妇女的颈椎僵硬度明显低于足月分娩的妇女。这一发现与其他方法的文献结果一致,表明可以在宫颈阴道暴露部分评估颈椎僵硬度。
{"title":"Cervical stiffness in mid-pregnancy: a predictive tool using a novel aspiration device for spontaneous preterm birth risk assessment","authors":"Irene Hösli MD, PhD,&nbsp;Gundula Hebisch MD,&nbsp;Michael Bajka MD,&nbsp;Katharina Quack Lötscher MPH MD,&nbsp;Alice Winkler MD,&nbsp;Leonhard Schäffer MD, PhD,&nbsp;Begoña Martinez de Tejada MD, PhD,&nbsp;Monya Todesco Bernasconi MD,&nbsp;Tina Fischer MD,&nbsp;Vincent Uerlings MD,&nbsp;Jute Richter MD, PhD,&nbsp;Stephanie Von Orelli MD,&nbsp;Markus Kuther MD,&nbsp;Elke Prentl MD,&nbsp;Ursula Fellmann MD,&nbsp;Alexander Krafft MD,&nbsp;Lea Köchli MD,&nbsp;Sabrina Badir DSc,&nbsp;David Scheiner MD","doi":"10.1016/j.ajogmf.2025.101867","DOIUrl":"10.1016/j.ajogmf.2025.101867","url":null,"abstract":"<div><h3>Video Abstract</h3><div><span><span><span><span><video><source></source></video></span><span><span>Download: <span>Download video (3MB)</span></span></span></span></span></span></div></div>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 2","pages":"Article 101867"},"PeriodicalIF":3.1,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145702183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Self-assessment of cardio-obstetric complexity and risk for pregnant adults with congenital heart disease 患有先天性心脏病的怀孕成人心脏-产科复杂性和风险的自我评估。
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-01 Epub Date: 2025-11-17 DOI: 10.1016/j.ajogmf.2025.101841
Sherrill Rose MD , Brianna Balansay MD , Oyinkansola Osobamiro MD , Shani Delaney MD , Jonathan Buber MD , Catherine Albright MD, MS , Mindy Pike PhD, MPH , Jill M. Steiner MD, MS
{"title":"Self-assessment of cardio-obstetric complexity and risk for pregnant adults with congenital heart disease","authors":"Sherrill Rose MD ,&nbsp;Brianna Balansay MD ,&nbsp;Oyinkansola Osobamiro MD ,&nbsp;Shani Delaney MD ,&nbsp;Jonathan Buber MD ,&nbsp;Catherine Albright MD, MS ,&nbsp;Mindy Pike PhD, MPH ,&nbsp;Jill M. Steiner MD, MS","doi":"10.1016/j.ajogmf.2025.101841","DOIUrl":"10.1016/j.ajogmf.2025.101841","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 2","pages":"Article 101841"},"PeriodicalIF":3.1,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145557581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of maternal Mediterranean diet on fetal cardiac function in high-risk pregnancies: a secondary analysis of the IMPACT BCN randomized trial 高危妊娠孕妇地中海饮食对胎儿心功能的影响。IMPACT BCN随机试验的二次分析。
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-01 Epub Date: 2025-12-17 DOI: 10.1016/j.ajogmf.2025.101875
Lina Youssef MD, PhD , Kenny Araujo MD , Lea Testa MD , Rommy Helena Novoa MD , Roger Borras MSc , Sara Castro-Barquero MD, PhD , Gabriel Bernardino PhD , Bart Bijnens MD, PhD , Francesca Crovetto MD, PhD , Eduard Gratacos MD, PhD , Fatima Crispi MD, PhD , study working group

BACKGROUND

Maternal suboptimal nutrition and high stress levels are associated with altered fetal cardiovascular function.

OBJECTIVE

This study aimed to assess the effect of structured maternal lifestyle interventions based on a Mediterranean diet or mindfulness-based stress reduction during pregnancy on fetal cardiac function.

STUDY DESIGN

This was a secondary analysis of the IMPACT BCN (Improving Mothers for a better PrenAtal Care Trial BarCeloNa) randomized clinical trial, which was conducted at a university hospital in Barcelona, Spain, from February 2017 to March 2020. A total of 1221 singleton pregnancies (19–23 weeks’ gestation) with high risk of delivering small-for-gestational-age newborns were randomly allocated into 3 groups in a 1:1:1 ratio: a Mediterranean diet intervention, a stress reduction program, or usual care. Participants in the Mediterranean diet group received monthly individual and group educational sessions and free provision of extra-virgin olive oil and walnuts. Those in the stress reduction group underwent an 8-week mindfulness-based stress reduction program adapted for pregnancy. Individuals in the usual care group received pregnancy care per institutional protocols. Fetal cardiac function was assessed using cord blood NT-proBNP (N-terminal probrain natriuretic peptide) and fetal echocardiography. NT-proBNP was measured in cord blood collected at delivery and considered high if >90th centile. Fetal echocardiography was performed at 33 to 34 weeks’ gestation. Data were analyzed from January to July 2024.

RESULTS

Fetal echocardiography and cord blood NT-proBNP measurements were obtained in 990 and 746 pregnancies, respectively. Whereas fetuses in the stress reduction group showed similar fetal cardiac results, the proportion of fetuses with high cord blood NT-proBNP concentrations was significantly lower in the Mediterranean diet group (6.4% vs 12%; P=.03) compared with the usual care group. Additionally, fetuses whose mothers followed the Mediterranean diet exhibited higher right ventricular fractional area change (mean [standard deviation], 30.4% [8.3] vs 28.1% [8.9]; P=.03) and thinner myocardial walls (mean [standard deviation], 2.95 [0.55] vs 3.16 [0.58] mm; P=.006) compared with the usual care group.

CONCLUSION

Promotion of a maternal Mediterranean diet intervention during pregnancy seems to be associated with a less overloaded and more efficient fetal heart. Future research is warranted to elucidate the mechanism(s) underlying these findings.
背景:母亲营养不良和高应激水平与胎儿心血管功能改变有关。目的:研究孕期以地中海饮食为基础的结构化产妇生活方式干预或正念减压干预对胎儿心功能的影响。研究设计:这是对IMPACT BCN(改善母亲产前护理巴塞罗那试验)随机临床试验的二次分析,该试验于2017年2月至2020年3月在西班牙巴塞罗那的一家大学医院进行。共有1221例单胎妊娠(19至23周妊娠)高危分娩小于胎龄新生儿的孕妇按1:1:1的比例随机分为三组:地中海饮食干预组、减压计划组和常规护理组。地中海饮食组的参与者每月接受个人和团体教育课程,并免费提供特级初榨橄榄油和核桃。减压组接受了为期8周的专为怀孕而设的正念减压计划。常规护理组的个体根据机构协议接受妊娠护理。采用脐血n端前b型利钠肽(NT-proBNP)和胎儿超声心动图评价胎儿心功能。NT-proBNP在分娩时采集的脐带血中测量,如果超过90百分位则认为是高的。在妊娠33-34周进行胎儿超声心动图检查。数据分析时间为2024年1月至7月。结果:990例和746例妊娠分别获得胎儿超声心动图和脐带血NT-proBNP。虽然减压组胎儿的心脏结果相似,但与常规护理组相比,地中海饮食组脐带血NT-proBNP浓度高的胎儿比例显著降低(6.4%比12%,p=0.03)。此外,母亲采用地中海饮食的胎儿右心室面积变化更高(平均(标准差)30.4(8.3)%比28.1 (8.9)%,p=0.03),心肌壁更薄(平均(标准差)2.95 (0.55)mm比3.16 (0.58)mm, p=0.006)。结论:在怀孕期间促进母亲地中海饮食干预似乎与一个更少超载和更有效的胎儿心脏有关。未来的研究有必要阐明这些发现背后的机制。
{"title":"Effects of maternal Mediterranean diet on fetal cardiac function in high-risk pregnancies: a secondary analysis of the IMPACT BCN randomized trial","authors":"Lina Youssef MD, PhD ,&nbsp;Kenny Araujo MD ,&nbsp;Lea Testa MD ,&nbsp;Rommy Helena Novoa MD ,&nbsp;Roger Borras MSc ,&nbsp;Sara Castro-Barquero MD, PhD ,&nbsp;Gabriel Bernardino PhD ,&nbsp;Bart Bijnens MD, PhD ,&nbsp;Francesca Crovetto MD, PhD ,&nbsp;Eduard Gratacos MD, PhD ,&nbsp;Fatima Crispi MD, PhD ,&nbsp;study working group","doi":"10.1016/j.ajogmf.2025.101875","DOIUrl":"10.1016/j.ajogmf.2025.101875","url":null,"abstract":"<div><h3>BACKGROUND</h3><div>Maternal suboptimal nutrition and high stress levels are associated with altered fetal cardiovascular function.</div></div><div><h3>OBJECTIVE</h3><div>This study aimed to assess the effect of structured maternal lifestyle interventions based on a Mediterranean diet or mindfulness-based stress reduction during pregnancy on fetal cardiac function.</div></div><div><h3>STUDY DESIGN</h3><div>This was a secondary analysis of the IMPACT BCN (Improving Mothers for a better PrenAtal Care Trial BarCeloNa) randomized clinical trial, which was conducted at a university hospital in Barcelona, Spain, from February 2017 to March 2020. A total of 1221 singleton pregnancies (19–23 weeks’ gestation) with high risk of delivering small-for-gestational-age newborns were randomly allocated into 3 groups in a 1:1:1 ratio: a Mediterranean diet intervention, a stress reduction program, or usual care. Participants in the Mediterranean diet group received monthly individual and group educational sessions and free provision of extra-virgin olive oil and walnuts. Those in the stress reduction group underwent an 8-week mindfulness-based stress reduction program adapted for pregnancy. Individuals in the usual care group received pregnancy care per institutional protocols. Fetal cardiac function was assessed using cord blood NT-proBNP (N-terminal probrain natriuretic peptide) and fetal echocardiography. NT-proBNP was measured in cord blood collected at delivery and considered high if &gt;90<sup>th</sup> centile. Fetal echocardiography was performed at 33 to 34 weeks’ gestation. Data were analyzed from January to July 2024.</div></div><div><h3>RESULTS</h3><div>Fetal echocardiography and cord blood NT-proBNP measurements were obtained in 990 and 746 pregnancies, respectively. Whereas fetuses in the stress reduction group showed similar fetal cardiac results, the proportion of fetuses with high cord blood NT-proBNP concentrations was significantly lower in the Mediterranean diet group (6.4% vs 12%; <em>P</em>=.03) compared with the usual care group. Additionally, fetuses whose mothers followed the Mediterranean diet exhibited higher right ventricular fractional area change (mean [standard deviation], 30.4% [8.3] vs 28.1% [8.9]; <em>P</em>=.03) and thinner myocardial walls (mean [standard deviation], 2.95 [0.55] vs 3.16 [0.58] mm; <em>P</em>=.006) compared with the usual care group.</div></div><div><h3>CONCLUSION</h3><div>Promotion of a maternal Mediterranean diet intervention during pregnancy seems to be associated with a less overloaded and more efficient fetal heart. Future research is warranted to elucidate the mechanism(s) underlying these findings.</div></div>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 2","pages":"Article 101875"},"PeriodicalIF":3.1,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145795001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing adherence to TRIPOD+AI guidelines in machine learning models for predicting small for gestational age and fetal growth restriction: a systematic review 评估在预测胎龄和胎儿生长受限的机器学习模型中对TRIPOD+AI指南的依从性:一项系统综述。
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-01 Epub Date: 2025-11-28 DOI: 10.1016/j.ajogmf.2025.101862
Giulia Zamagni MSc , Camilla Fregona MD , Moira Barbieri MD , Maria Sole Scalia MD , Lorenzo Monasta DSc , Christoph Lees MD, PhD , Tamara Stampalija MD, PhD , Giulia Barbati PhD

Objectives

Fetal growth restriction (FGR) significantly contribute to perinatal morbidity, mortality, and long-term adverse health outcomes. While small for gestational age (SGA) is often used as a proxy for FGR, it does not necessarily indicate pathological growth restriction. Given the increasing interest in machine learning (ML) for predicting FGR/SGA, this study systematically reviews ML applications in this domain, evaluating their methodological rigor and reporting quality, following standardized guidelines.

Data Sources

The systematic search was conducted in MEDLINE and Scopus on June 21, 2024, following PRISMA 2020 guidelines.

Study Eligibility Criteria

Eligible studies implemented ML models for FGR/SGA prediction using routinely available clinical variables and reported at least one area under the receiver operating characteristic (AUROC) and/or accuracy. Exclusions included preprints, conference abstracts, systematic reviews, animal studies, and models relying exclusively on biomarkers or genomics, as not part of the clinical practice.

Study Appraisal and Synthesis Methods

Two independent reviewers screened articles with the help of the Rayyan software. Risk of bias was assessed using the PROBAST checklist. Adherence to the guidelines on the transparent reporting of a multivariable prediction model for individual prognosis or diagnosis+artificial intelligence (TRIPOD+AI) was evaluated across methods, results, and discussion sections using a 4-point Likert scale. Sample size adequacy was assessed for each study, accounting for outcome type, predictors, and outcome prevalence.

Results

The search identified 272 studies, with 20 meeting the inclusion criteria. Definitions of FGR/SGA were inconsistent, particularly in technical journals. Adherence to TRIPOD+AI guidelines was variable, as no model reported on fairness or heterogeneity across relevant subgroups, and only 15% reported on calibration. Only 30% of studies met the minimum sample size required for ML models, indicating potential overfitting and limited generalizability.

Conclusion

Despite the potential of ML models in predicting FGR/SGA, key limitations persist, including inconsistent outcome definitions, underpowered models, and suboptimal reporting of calibration and clinical applicability. Future studies should emphasize standardized definitions, robust sample sizes, and comprehensive reporting to enhance model reliability and clinical translation.

Video Abstract

Download: Download video (4MB)

Video.

目的:胎儿生长受限(FGR)显著影响围产期发病率、死亡率和长期不良健康结果。虽然小胎龄(SGA)经常被用作FGR的替代指标,但它并不一定表明病理性生长受限。鉴于人们对预测FGR/SGA的机器学习(ML)越来越感兴趣,本研究系统地回顾了该领域的ML应用,评估了其方法的严谨性和报告质量,并遵循了标准化的指导方针。数据来源:按照PRISMA 2020指南,于2024年6月21日在MEDLINE和Scopus中进行系统检索。研究资格标准:符合条件的研究使用常规可用的临床变量实施ML模型进行FGR/SGA预测,并报告至少一个区域低于受试者操作特征(AUROC)和/或准确性。排除包括预印本、会议摘要、系统综述、动物研究和完全依赖生物标志物或基因组学的模型,而不是临床实践的一部分。研究评价和综合方法:两位独立审稿人在Rayyan软件的帮助下对文章进行筛选。使用PROBAST检查表评估偏倚风险。采用4点李克特量表对个体预后或诊断多变量预测模型透明报告指南 + 人工智能(TRIPOD+AI)的依从性进行了方法、结果和讨论部分的评估。对每项研究的样本量充分性进行评估,考虑结果类型、预测因素和结果患病率。结果:检索确定了272项研究,其中20项符合纳入标准。FGR/SGA的定义不一致,特别是在技术期刊上。对TRIPOD+AI指南的依从性是可变的,因为没有模型报告相关亚组的公平性或异质性,只有15%的模型报告了校准。只有30%的研究满足ML模型所需的最小样本量,表明潜在的过拟合和有限的推广能力。结论:尽管ML模型在预测FGR/SGA方面具有潜力,但主要的局限性仍然存在,包括结果定义不一致、模型功能不足、校准报告和临床适用性不理想。未来的研究应强调标准化的定义、稳健的样本量和全面的报告,以提高模型的可靠性和临床翻译。
{"title":"Assessing adherence to TRIPOD+AI guidelines in machine learning models for predicting small for gestational age and fetal growth restriction: a systematic review","authors":"Giulia Zamagni MSc ,&nbsp;Camilla Fregona MD ,&nbsp;Moira Barbieri MD ,&nbsp;Maria Sole Scalia MD ,&nbsp;Lorenzo Monasta DSc ,&nbsp;Christoph Lees MD, PhD ,&nbsp;Tamara Stampalija MD, PhD ,&nbsp;Giulia Barbati PhD","doi":"10.1016/j.ajogmf.2025.101862","DOIUrl":"10.1016/j.ajogmf.2025.101862","url":null,"abstract":"<div><h3>Objectives</h3><div>Fetal growth restriction (FGR) significantly contribute to perinatal morbidity, mortality, and long-term adverse health outcomes. While small for gestational age (SGA) is often used as a proxy for FGR, it does not necessarily indicate pathological growth restriction. Given the increasing interest in machine learning (ML) for predicting FGR/SGA, this study systematically reviews ML applications in this domain, evaluating their methodological rigor and reporting quality, following standardized guidelines.</div></div><div><h3>Data Sources</h3><div>The systematic search was conducted in MEDLINE and Scopus on June 21, 2024, following PRISMA 2020 guidelines.</div></div><div><h3>Study Eligibility Criteria</h3><div>Eligible studies implemented ML models for FGR/SGA prediction using routinely available clinical variables and reported at least one area under the receiver operating characteristic (AUROC) and/or accuracy. Exclusions included preprints, conference abstracts, systematic reviews, animal studies, and models relying exclusively on biomarkers or genomics, as not part of the clinical practice.</div></div><div><h3>Study Appraisal and Synthesis Methods</h3><div>Two independent reviewers screened articles with the help of the Rayyan software. Risk of bias was assessed using the PROBAST checklist. Adherence to the guidelines on the transparent reporting of a multivariable prediction model for individual prognosis or diagnosis+artificial intelligence (TRIPOD+AI) was evaluated across methods, results, and discussion sections using a 4-point Likert scale. Sample size adequacy was assessed for each study, accounting for outcome type, predictors, and outcome prevalence.</div></div><div><h3>Results</h3><div>The search identified 272 studies, with 20 meeting the inclusion criteria. Definitions of FGR/SGA were inconsistent, particularly in technical journals. Adherence to TRIPOD+AI guidelines was variable, as no model reported on fairness or heterogeneity across relevant subgroups, and only 15% reported on calibration. Only 30% of studies met the minimum sample size required for ML models, indicating potential overfitting and limited generalizability.</div></div><div><h3>Conclusion</h3><div>Despite the potential of ML models in predicting FGR/SGA, key limitations persist, including inconsistent outcome definitions, underpowered models, and suboptimal reporting of calibration and clinical applicability. Future studies should emphasize standardized definitions, robust sample sizes, and comprehensive reporting to enhance model reliability and clinical translation.</div></div><div><h3>Video Abstract</h3><div><span><span><span><span><video><source></source></video></span><span><span>Download: <span>Download video (4MB)</span></span></span></span><span><span><p><span>Video</span>. </p></span></span></span></span></div></div>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 2","pages":"Article 101862"},"PeriodicalIF":3.1,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145649119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond 23+6: rethinking cerclage eligibility in the age of early viability 超越23+6:重新思考早期生存能力时代的循环资格。
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-01 Epub Date: 2025-12-06 DOI: 10.1016/j.ajogmf.2025.101868
Arielle J. Higgs MD , Karl E. Seif MD
{"title":"Beyond 23+6: rethinking cerclage eligibility in the age of early viability","authors":"Arielle J. Higgs MD ,&nbsp;Karl E. Seif MD","doi":"10.1016/j.ajogmf.2025.101868","DOIUrl":"10.1016/j.ajogmf.2025.101868","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 2","pages":"Article 101868"},"PeriodicalIF":3.1,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145709976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In reply: Interpretation of subgroup findings and methodologic considerations in the cerclage individual patient data meta-analysis 回复:在环裂患者个体数据荟萃分析中对亚组结果的解释和方法学考虑。
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-01 Epub Date: 2026-02-02 DOI: 10.1016/j.ajogmf.2025.101864
Vincenzo Berghella MD, Gabriele Saccone MD, Rupsa Boelig MD
{"title":"In reply: Interpretation of subgroup findings and methodologic considerations in the cerclage individual patient data meta-analysis","authors":"Vincenzo Berghella MD,&nbsp;Gabriele Saccone MD,&nbsp;Rupsa Boelig MD","doi":"10.1016/j.ajogmf.2025.101864","DOIUrl":"10.1016/j.ajogmf.2025.101864","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 2","pages":"Article 101864"},"PeriodicalIF":3.1,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146120611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American Journal of Obstetrics & Gynecology Mfm
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1